JSJCX
Price
$16.24
Change
-$0.05 (-0.31%)
Updated
Oct 17 closing price
Net Assets
542.91M
NRGSX
Price
$62.80
Change
+$0.25 (+0.40%)
Updated
Oct 17 closing price
Net Assets
8.68B
Interact to see
Advertisement

JSJCX vs NRGSX

Header iconJSJCX vs NRGSX Comparison
Open Charts JSJCX vs NRGSXBanner chart's image
JHancock Small Cap Dynamic Growth C
Price$16.24
Change-$0.05 (-0.31%)
VolumeN/A
Net Assets542.91M
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.68B
JSJCX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
JSJCX vs. NRGSX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSJCX is a Hold and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.69B vs. JSJCX (543M). JSJCX pays higher dividends than NRGSX: JSJCX (2.41) vs NRGSX (0.06). JSJCX was incepted earlier than NRGSX: JSJCX (8 years) vs NRGSX (13 years). JSJCX (2.10) is less costly to investors than NRGSX (0.74). JSJCX is a more actively managed with annual turnover of: 177.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than JSJCX: NRGSX (0) vs JSJCX (1000). JSJCX annual gain was more profitable for investors over the last year : -1.27 vs. NRGSX (-10.47). NRGSX return over 5 years is better than : -2.71 vs. JSJCX (-18.64).
JSJCXNRGSXJSJCX / NRGSX
Total Expense Ratio1.950.74264%
Annual Report Gross Expense Ratio2.100.74284%
Fund Existence8 years13 years-
Gain YTD5.369-4.285-125%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets543M8.69B6%
Annual Yield % from dividends2.410.063,706%
Returns for 1 year-1.27-10.4712%
Returns for 3 years28.125.48513%
Returns for 5 years-18.64-2.71688%
Returns for 10 yearsN/A9.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLBAX38.930.05
+0.13%
American Funds American Balanced 529A
CCERX29.79N/A
N/A
Columbia Large Cap Enhanced Core R
RYVYX691.86N/A
N/A
Rydex NASDAQ-100® 2x Strategy H
FCVIX19.90N/A
N/A
Fidelity Advisor Small Cap Value I
GMVAX16.43N/A
N/A
Goldman Sachs Small/Mid Cap Equity A